Brief Description
DNA Nanobots is focused on developing the next generation of targeted nanomedicines and reshaping gene therapy by delivering genes previously considered undeliverable. Utilizing precise DNA self-assembly (DNA origami), the company engineers nanobots designed to carry and release therapeutic payloads directly to diseased cells with unprecedented specificity, minimizing systemic toxicity, and maximizing treatment efficacy.
Inventors
Jennifer Doudna, Enrique Lin Shiao, Rachael Lew
Company Founders
Patrick Halley, Christopher Lucas, Carlos Castro, Adel Mikhail, Melika Shahhosseini, Jeffrey Spitzner
Timeline
- 2021. Company founded.